ORKA
Oruka Therapeutics, Inc.
82.10$
+6.3%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.17 | 0.16 | 0.13 | 0.11 | 0.10 | 0.08 | 0.09 | 0.08 | 0.28 | 0.21 | 0.17 | 0.18 | 0.19 | 0.17 | 0.05 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | 0.00 | 0.00 | – | |
| -0.17 | -0.16 | -0.13 | -0.11 | -0.10 | -0.08 | -0.09 | -0.08 | -0.28 | -0.21 | -0.17 | -0.18 | -0.19 | -0.17 | -0.05 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | 0.00 | 0.00 | – | |
| 77.10 | 104.42 | 65.50 | 51.99 | 27.28 | 17.90 | 11.48 | 9.70 | 8.87 | 4.18 | 2.74 | 2.89 | 2.75 | 2.49 | 2.09 | 4.03 | 2.79 | 2.98 | 2.86 | 3.28 | 1.81 | 0.83 | 0.44 | 0.22 | 0.03 | 0.02 | 0.02 | 0.00 | 0.01 | 1.29 | 1.71 | 1.93 | 0.48 | 0.57 | 0.66 | 0.51 | 0.53 | 0.69 | 2.05 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.12 | 0.19 | 0.24 | 0.34 | 0.12 | 0.10 | 0.11 | 0.12 | 0.13 | 0.11 | 0.41 | |
| 103.89 | 128.61 | 83.90 | 78.71 | 43.88 | 33.37 | 25.69 | 23.61 | 23.57 | 14.11 | 9.66 | 9.44 | 9.90 | 8.59 | 3.90 | 6.42 | 3.97 | 4.01 | 3.90 | 4.71 | 2.71 | 2.00 | 1.44 | 1.29 | 0.12 | 0.13 | 0.13 | 0.11 | 0.17 | 1.48 | 1.96 | 2.28 | 0.60 | 0.67 | 0.77 | 0.63 | 0.66 | 0.80 | 2.46 | |
| -104.05 | -128.77 | -84.03 | -78.82 | -43.98 | -33.45 | -25.78 | -23.69 | -23.85 | -14.32 | -9.84 | -9.62 | -10.09 | -8.76 | -3.95 | -6.44 | -3.98 | -4.03 | -3.93 | -4.73 | -2.73 | -2.02 | -1.47 | -1.32 | -0.12 | -0.14 | -0.13 | -0.11 | -0.17 | -1.48 | -1.96 | -2.28 | -0.60 | -0.67 | -0.77 | -0.63 | -0.66 | -0.80 | -2.47 | |
| – | – | – | – | – | – | – | – | – | 0.03 | 0.01 | – | 0.03 | 0.02 | 0.00 | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.01 | 0.05 | 0.03 | – | 0.00 | 0.00 | 0.00 | 0.00 | – | – | – | |
| -103.03 | -127.91 | -83.24 | -78.11 | -43.37 | -32.83 | -25.19 | -23.10 | -23.38 | -13.89 | -9.45 | -9.35 | -9.94 | -8.77 | -3.95 | -6.44 | -3.98 | -4.03 | -3.92 | -4.73 | -2.72 | -2.62 | -1.94 | -0.98 | -0.09 | -0.10 | -0.10 | -0.08 | -0.14 | -1.53 | -1.91 | -1.99 | -0.50 | -0.58 | -0.69 | -0.54 | -0.58 | -0.66 | -2.11 | |
| – | – | – | -1.12 | – | – | -0.48 | – | -1.10 | -0.26 | -0.33 | -0.12 | – | -0.06 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -103.03 | -127.91 | -83.24 | -76.99 | -43.37 | -32.83 | -24.71 | -23.10 | -22.29 | -13.64 | -9.12 | -9.23 | -9.94 | -8.71 | -3.95 | -6.44 | -3.98 | -4.03 | -3.92 | -4.73 | -2.72 | -2.62 | -1.94 | -0.98 | -0.09 | -0.10 | -0.10 | -0.08 | -0.14 | -1.53 | -1.91 | -1.99 | -0.50 | -0.58 | -0.69 | -0.54 | -0.58 | -0.66 | -2.11 | |
| -102.87 | -127.75 | -83.11 | -78.00 | -43.28 | -32.75 | -25.10 | -23.02 | -23.10 | -13.65 | -9.27 | -9.17 | -9.72 | -8.58 | -3.90 | -6.42 | -3.97 | -4.01 | -3.90 | -4.70 | -2.70 | -2.60 | -1.92 | -0.95 | -0.09 | -0.10 | -0.10 | -0.07 | -0.14 | -1.53 | -1.87 | -2.23 | -0.50 | -0.58 | -0.69 | -0.54 | -0.58 | -0.80 | -2.25 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.